Amiselimod, a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Has Potent Therapeutic Efficacy for Autoimmune Diseases, with Low Bradycardia RiskKunio Sugahara, Yasuhiro Maeda & 12 more2016PDF703 KBEN